Skip to main content
TipRanks
Go Ultimate75% OFF

MariMed (MRMD) Stock Statistics & Valuation Metrics

4 Followers

Total Valuation

MariMed has a market cap or net worth of CAD 33.40M. The enterprise value is CAD 113.35M.

Market Cap
CAD 33.40M
Enterprise Value
CAD 113.35M

Share Statistics

MariMed has 405,996,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
405,996,000
Owned by Insiders
10.78%
Owned by Institutions
0.02%

Financial Efficiency

MariMed’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -1.38%.

Return on Equity (ROE)
-0.28
Return on Assets (ROA)
-0.07
Return on Invested Capital (ROIC)
-1.38%
Return on Capital Employed (ROCE)
-0.01
Revenue Per Employee
184.56K
Profits Per Employee
-16.73K
Employee Count
866
Asset Turnover
0.79
Inventory Turnover
2.79

Valuation Ratios

The current PE Ratio of MariMed is -1.46. MariMed’s PEG ratio is -0.16.

PE Ratio
-1.46
PS Ratio
0.14
PB Ratio
0.54
Price to FCF
2.50
Price to Operating Cash Flow
2.26
PEG Ratio
-0.16

Income Statement

In the last 12 months, MariMed had revenue of 159.83M and earned -14.48M in profits. Earnings per share was -0.04.

Revenue
159.83M
Gross Profit
57.88M
Operating Income
-2.07M
Pretax Income
-10.86M
Net Income
-14.48M
EBITDA
9.44M
Earnings Per Share (EPS)
-0.04

Cash Flow

In the last 12 months, operating cash flow was 10.08M and capital expenditures -949,000, giving a free cash flow of 9.13M billion.

Operating Cash Flow
10.08M
Free Cash Flow
9.13M
Free Cash Flow per Share
0.02

Dividends & Yields

MariMed pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
41.13%
Earnings Yield
-69.98%

Stock Price Statistics

Beta
0.89
52-Week Price Change
-34.78%
50-Day Moving Average
0.10
200-Day Moving Average
0.10
Relative Strength Index (RSI)
39.00
Average Volume (3m)
58.08K

Important Dates

MariMed upcoming earnings date is Mar 17, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 11, 2026
Next Earnings Date
Mar 17, 2027
Ex-Dividend Date
―

Financial Position

MariMed as a current ratio of 1.00, with Debt / Equity ratio of 192.96%

Current Ratio
1.00
Quick Ratio
0.38
Debt to Market Cap
2.55
Net Debt to EBITDA
9.66
Interest Coverage Ratio
-0.28

Taxes

In the past 12 months, MariMed has paid 3.59M in taxes.

Income Tax
3.59M
Effective Tax Rate
-0.33

Enterprise Valuation

MariMed EV to EBITDA ratio is 10.95, with an EV/FCF ratio of 11.96.

EV to Sales
0.65
EV to EBITDA
10.95
EV to Free Cash Flow
11.96
EV to Operating Cash Flow
10.84

Balance Sheet

MariMed has CAD 10.36M in cash and marketable securities with CAD 97.42M in debt, giving a net cash position of -CAD 87.06M billion.

Cash & Marketable Securities
CAD 10.36M
Total Debt
CAD 97.42M
Net Cash
-CAD 87.06M
Net Cash Per Share
-CAD 0.21
Tangible Book Value Per Share
CAD 0.02

Margins

Gross margin is 35.37%, with operating margin of -1.03%, and net profit margin of -9.27%.

Gross Margin
35.37%
Operating Margin
-1.03%
Pretax Margin
-6.53%
Net Profit Margin
-9.27%
EBITDA Margin
5.96%
EBIT Margin
-1.29%

Analyst Forecast

The average price target for MariMed is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
5.54%
EPS Growth Forecast
17.43%